nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—hypertension	0.137	0.743	CbGaD
Tasosartan—Candesartan—hypertension	0.0788	0.237	CrCtD
Tasosartan—Irbesartan—hypertension	0.0732	0.22	CrCtD
Tasosartan—Olmesartan—hypertension	0.0653	0.196	CrCtD
Tasosartan—Valsartan—hypertension	0.0623	0.187	CrCtD
Tasosartan—Losartan—hypertension	0.0529	0.159	CrCtD
Tasosartan—AGTR1—hypertension	0.0473	0.257	CbGaD
Tasosartan—AGTR1—Eprosartan—hypertension	0.0414	0.21	CbGbCtD
Tasosartan—AGTR1—Candesartan—hypertension	0.0314	0.159	CbGbCtD
Tasosartan—AGTR1—Olmesartan—hypertension	0.028	0.142	CbGbCtD
Tasosartan—AGTR1—Telmisartan—hypertension	0.0224	0.113	CbGbCtD
Tasosartan—AGTR1—Valsartan—hypertension	0.0218	0.11	CbGbCtD
Tasosartan—AGTR1—Irbesartan—hypertension	0.0194	0.0984	CbGbCtD
Tasosartan—Losartan—Eprosartan—hypertension	0.0159	0.0688	CrCrCtD
Tasosartan—AGTR1—Losartan—hypertension	0.0125	0.0634	CbGbCtD
Tasosartan—Azilsartan medoxomil—Candesartan—hypertension	0.0101	0.0438	CrCrCtD
Tasosartan—Azilsartan medoxomil—Telmisartan—hypertension	0.0101	0.0438	CrCrCtD
Tasosartan—Forasartan—Candesartan—hypertension	0.00873	0.0379	CrCrCtD
Tasosartan—Irbesartan—Candesartan—hypertension	0.00873	0.0379	CrCrCtD
Tasosartan—Valsartan—Candesartan—hypertension	0.00873	0.0379	CrCrCtD
Tasosartan—Azilsartan medoxomil—Olmesartan—hypertension	0.00837	0.0363	CrCrCtD
Tasosartan—Valsartan—Irbesartan—hypertension	0.00812	0.0352	CrCrCtD
Tasosartan—Forasartan—Irbesartan—hypertension	0.00812	0.0352	CrCrCtD
Tasosartan—Forasartan—Olmesartan—hypertension	0.00724	0.0314	CrCrCtD
Tasosartan—Irbesartan—Olmesartan—hypertension	0.00724	0.0314	CrCrCtD
Tasosartan—Valsartan—Olmesartan—hypertension	0.00724	0.0314	CrCrCtD
Tasosartan—Olmesartan—Telmisartan—hypertension	0.00694	0.0301	CrCrCtD
Tasosartan—Olmesartan—Candesartan—hypertension	0.00694	0.0301	CrCrCtD
Tasosartan—Forasartan—Valsartan—hypertension	0.0069	0.0299	CrCrCtD
Tasosartan—Irbesartan—Valsartan—hypertension	0.0069	0.0299	CrCrCtD
Tasosartan—Azilsartan medoxomil—Losartan—hypertension	0.00679	0.0295	CrCrCtD
Tasosartan—Olmesartan—Irbesartan—hypertension	0.00645	0.028	CrCrCtD
Tasosartan—Losartan—Candesartan—hypertension	0.00631	0.0274	CrCrCtD
Tasosartan—Losartan—Telmisartan—hypertension	0.00631	0.0274	CrCrCtD
Tasosartan—Forasartan—Losartan—hypertension	0.00587	0.0255	CrCrCtD
Tasosartan—Valsartan—Losartan—hypertension	0.00587	0.0255	CrCrCtD
Tasosartan—Irbesartan—Losartan—hypertension	0.00587	0.0255	CrCrCtD
Tasosartan—Losartan—Irbesartan—hypertension	0.00587	0.0255	CrCrCtD
Tasosartan—Candesartan—Telmisartan—hypertension	0.0058	0.0252	CrCrCtD
Tasosartan—Olmesartan—Valsartan—hypertension	0.00548	0.0238	CrCrCtD
Tasosartan—Candesartan—Irbesartan—hypertension	0.00539	0.0234	CrCrCtD
Tasosartan—Losartan—Olmesartan—hypertension	0.00523	0.0227	CrCrCtD
Tasosartan—Losartan—Valsartan—hypertension	0.00499	0.0217	CrCrCtD
Tasosartan—Candesartan—Olmesartan—hypertension	0.00481	0.0209	CrCrCtD
Tasosartan—Olmesartan—Losartan—hypertension	0.00466	0.0202	CrCrCtD
Tasosartan—Candesartan—Valsartan—hypertension	0.00459	0.0199	CrCrCtD
Tasosartan—Candesartan—Losartan—hypertension	0.0039	0.0169	CrCrCtD
Tasosartan—CYP3A4—Guanethidine—hypertension	0.00224	0.0114	CbGbCtD
Tasosartan—CYP3A4—Hydralazine—hypertension	0.0017	0.00862	CbGbCtD
Tasosartan—CYP3A4—Guanfacine—hypertension	0.00144	0.00733	CbGbCtD
Tasosartan—AGTR1—nephron—hypertension	0.00141	0.122	CbGeAlD
Tasosartan—CYP3A4—Isradipine—hypertension	0.00129	0.00653	CbGbCtD
Tasosartan—AGTR2—cardiovascular system—hypertension	0.00122	0.106	CbGeAlD
Tasosartan—AGTR2—kidney—hypertension	0.00119	0.103	CbGeAlD
Tasosartan—CYP3A4—Indapamide—hypertension	0.00113	0.00575	CbGbCtD
Tasosartan—CYP3A4—Nisoldipine—hypertension	0.00113	0.00575	CbGbCtD
Tasosartan—CYP3A4—Eplerenone—hypertension	0.00109	0.00556	CbGbCtD
Tasosartan—CYP3A4—Diltiazem—hypertension	0.00109	0.00556	CbGbCtD
Tasosartan—CYP3A4—Enalapril—hypertension	0.000976	0.00495	CbGbCtD
Tasosartan—CYP3A4—Irbesartan—hypertension	0.000892	0.00453	CbGbCtD
Tasosartan—CYP3A4—Amlodipine—hypertension	0.000875	0.00444	CbGbCtD
Tasosartan—CYP3A4—Felodipine—hypertension	0.000844	0.00428	CbGbCtD
Tasosartan—AGTR2—endocrine gland—hypertension	0.000836	0.0725	CbGeAlD
Tasosartan—CYP3A4—Nifedipine—hypertension	0.000816	0.00414	CbGbCtD
Tasosartan—CYP3A4—Carvedilol—hypertension	0.000803	0.00408	CbGbCtD
Tasosartan—CYP3A4—Nicardipine—hypertension	0.000803	0.00408	CbGbCtD
Tasosartan—AGTR1—artery—hypertension	0.000785	0.0681	CbGeAlD
Tasosartan—CYP3A4—Propranolol—hypertension	0.000739	0.00375	CbGbCtD
Tasosartan—CYP3A4—Clonidine—hypertension	0.000705	0.00358	CbGbCtD
Tasosartan—AGTR1—endothelium—hypertension	0.000663	0.0576	CbGeAlD
Tasosartan—CYP3A4—Atorvastatin—hypertension	0.000629	0.00319	CbGbCtD
Tasosartan—AGTR1—blood vessel—hypertension	0.000612	0.0531	CbGeAlD
Tasosartan—CYP3A4—Losartan—hypertension	0.000575	0.00292	CbGbCtD
Tasosartan—CYP3A4—Verapamil—hypertension	0.000507	0.00258	CbGbCtD
Tasosartan—AGTR1—cardiac ventricle—hypertension	0.00044	0.0382	CbGeAlD
Tasosartan—CYP3A4—urine—hypertension	0.000415	0.036	CbGeAlD
Tasosartan—AGTR1—myocardium—hypertension	0.000414	0.0359	CbGeAlD
Tasosartan—AGTR1—nephron tubule—hypertension	0.000304	0.0264	CbGeAlD
Tasosartan—AGTR1—adrenal cortex—hypertension	0.000299	0.0259	CbGeAlD
Tasosartan—AGTR1—heart—hypertension	0.000289	0.0251	CbGeAlD
Tasosartan—AGTR1—smooth muscle tissue—hypertension	0.000287	0.0249	CbGeAlD
Tasosartan—AGTR1—decidua—hypertension	0.000281	0.0244	CbGeAlD
Tasosartan—AGTR1—cardiovascular system—hypertension	0.000273	0.0237	CbGeAlD
Tasosartan—AGTR1—kidney—hypertension	0.000267	0.0232	CbGeAlD
Tasosartan—AGTR1—cortex of kidney—hypertension	0.00026	0.0226	CbGeAlD
Tasosartan—Azilsartan medoxomil—AGTR1—hypertension	0.000259	0.191	CrCbGaD
Tasosartan—AGTR1—cardiac atrium—hypertension	0.000247	0.0215	CbGeAlD
Tasosartan—Forasartan—AGTR1—hypertension	0.000241	0.178	CrCbGaD
Tasosartan—AGTR1—medulla oblongata—hypertension	0.000233	0.0202	CbGeAlD
Tasosartan—AGTR1—adrenal gland—hypertension	0.000216	0.0187	CbGeAlD
Tasosartan—AGTR1—endocrine gland—hypertension	0.000187	0.0162	CbGeAlD
Tasosartan—AGTR1—central nervous system—hypertension	0.000169	0.0146	CbGeAlD
Tasosartan—Irbesartan—EDNRA—hypertension	0.000144	0.106	CrCbGaD
Tasosartan—Valsartan—AGTR1—hypertension	0.000126	0.0934	CrCbGaD
Tasosartan—Olmesartan—AGTR1—hypertension	0.000123	0.091	CrCbGaD
Tasosartan—CYP3A4—kidney—hypertension	9.8e-05	0.00851	CbGeAlD
Tasosartan—Candesartan—AGTR1—hypertension	9.58e-05	0.0707	CrCbGaD
Tasosartan—Irbesartan—AGTR1—hypertension	9.58e-05	0.0707	CrCbGaD
Tasosartan—CYP3A4—endocrine gland—hypertension	6.87e-05	0.00596	CbGeAlD
Tasosartan—CYP3A4—central nervous system—hypertension	6.19e-05	0.00537	CbGeAlD
Tasosartan—Losartan—AGTR1—hypertension	6.17e-05	0.0456	CrCbGaD
Tasosartan—Irbesartan—PTGS1—hypertension	4.45e-05	0.0329	CrCbGaD
Tasosartan—Candesartan—PTGS1—hypertension	4.45e-05	0.0329	CrCbGaD
Tasosartan—Losartan—CYP3A5—hypertension	3.87e-05	0.0286	CrCbGaD
Tasosartan—Losartan—ACE—hypertension	3.57e-05	0.0263	CrCbGaD
Tasosartan—Valsartan—ALB—hypertension	2.99e-05	0.0221	CrCbGaD
Tasosartan—Losartan—ALB—hypertension	1.46e-05	0.0108	CrCbGaD
Tasosartan—AGTR1—Signaling Pathways—ANXA1—hypertension	2.88e-06	6.66e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR3—hypertension	2.88e-06	6.66e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EP300—hypertension	2.87e-06	6.65e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IKBKB—hypertension	2.85e-06	6.6e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGT—hypertension	2.83e-06	6.56e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SST—hypertension	2.8e-06	6.48e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDNRA—hypertension	2.8e-06	6.48e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SRC—hypertension	2.79e-06	6.46e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALM1—hypertension	2.79e-06	6.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD3—hypertension	2.79e-06	6.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FLT1—hypertension	2.79e-06	6.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB1—hypertension	2.79e-06	6.45e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CYBA—hypertension	2.79e-06	6.45e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—COMT—hypertension	2.76e-06	6.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRA2A—hypertension	2.74e-06	6.34e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLAT—hypertension	2.73e-06	6.32e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GHRL—hypertension	2.73e-06	6.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—COMT—hypertension	2.72e-06	6.3e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—hypertension	2.72e-06	6.29e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALCA—hypertension	2.69e-06	6.24e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB2—hypertension	2.63e-06	6.09e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—hypertension	2.63e-06	6.08e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—F2—hypertension	2.62e-06	6.07e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCB—hypertension	2.62e-06	6.07e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRBK1—hypertension	2.6e-06	6.03e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR1—hypertension	2.58e-06	5.98e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALM2—hypertension	2.55e-06	5.92e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT2—hypertension	2.52e-06	5.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—hypertension	2.52e-06	5.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR7—hypertension	2.52e-06	5.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD2—hypertension	2.52e-06	5.84e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MYC—hypertension	2.5e-06	5.79e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTPN1—hypertension	2.49e-06	5.78e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—hypertension	2.49e-06	5.78e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GCG—hypertension	2.49e-06	5.78e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	2.49e-06	5.76e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH2—hypertension	2.45e-06	5.66e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KL—hypertension	2.45e-06	5.66e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—hypertension	2.45e-06	5.66e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITGAV—hypertension	2.4e-06	5.56e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGFR—hypertension	2.4e-06	5.56e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KNG1—hypertension	2.39e-06	5.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A1—hypertension	2.39e-06	5.54e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—hypertension	2.39e-06	5.53e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRL—hypertension	2.38e-06	5.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FAH—hypertension	2.36e-06	5.46e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	2.36e-06	5.46e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STK11—hypertension	2.34e-06	5.43e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HDAC1—hypertension	2.34e-06	5.43e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—hypertension	2.33e-06	5.41e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL10—hypertension	2.32e-06	5.39e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLG—hypertension	2.32e-06	5.37e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RHOA—hypertension	2.31e-06	5.36e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT2—hypertension	2.29e-06	5.31e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3R1—hypertension	2.29e-06	5.31e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB2—hypertension	2.26e-06	5.23e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCE—hypertension	2.23e-06	5.16e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFA—hypertension	2.2e-06	5.1e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VAV3—hypertension	2.2e-06	5.1e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFBR2—hypertension	2.17e-06	5.03e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNB3—hypertension	2.15e-06	4.98e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVP—hypertension	2.12e-06	4.91e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RHOA—hypertension	2.1e-06	4.87e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GNAS—hypertension	2.09e-06	4.85e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3R1—hypertension	2.08e-06	4.82e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—hypertension	2.05e-06	4.76e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOB—hypertension	2.05e-06	4.75e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTK2—hypertension	2.04e-06	4.73e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—hypertension	2.03e-06	4.71e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDN1—hypertension	2.02e-06	4.67e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL5—hypertension	2e-06	4.64e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LPL—hypertension	1.96e-06	4.53e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—H2AFX—hypertension	1.94e-06	4.5e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFRB—hypertension	1.94e-06	4.49e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RPS6KB1—hypertension	1.94e-06	4.49e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY5—hypertension	1.92e-06	4.44e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCG—hypertension	1.9e-06	4.41e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITGB3—hypertension	1.89e-06	4.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCA—hypertension	1.89e-06	4.38e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—hypertension	1.88e-06	4.35e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—YWHAZ—hypertension	1.87e-06	4.34e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGF—hypertension	1.85e-06	4.29e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SPP1—hypertension	1.85e-06	4.29e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—hypertension	1.85e-06	4.27e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—hypertension	1.8e-06	4.18e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCD—hypertension	1.8e-06	4.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HYAL2—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—QDPR—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HAS3—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HAS2—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HAS1—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PNMT—hypertension	1.79e-06	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—hypertension	1.78e-06	4.13e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—hypertension	1.76e-06	4.09e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C3—hypertension	1.76e-06	4.08e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—hypertension	1.73e-06	4.02e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFB—hypertension	1.71e-06	3.97e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGFR1—hypertension	1.71e-06	3.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTA5—hypertension	1.68e-06	3.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HIF1A—hypertension	1.68e-06	3.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGT—hypertension	1.67e-06	3.88e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALM1—hypertension	1.65e-06	3.81e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—hypertension	1.64e-06	3.8e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—hypertension	1.64e-06	3.8e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CAV1—hypertension	1.63e-06	3.76e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOA1—hypertension	1.62e-06	3.76e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KDR—hypertension	1.61e-06	3.72e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT2—hypertension	1.59e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MDH1—hypertension	1.59e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HYAL1—hypertension	1.59e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CPS1—hypertension	1.59e-06	3.69e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CDO1—hypertension	1.59e-06	3.69e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—F2—hypertension	1.55e-06	3.58e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCB—hypertension	1.55e-06	3.58e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—hypertension	1.55e-06	3.58e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCH1—hypertension	1.52e-06	3.52e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP4F12—hypertension	1.52e-06	3.52e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH1—hypertension	1.51e-06	3.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCD1—hypertension	1.46e-06	3.38e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—hypertension	1.41e-06	3.26e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AHCY—hypertension	1.4e-06	3.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP11B1—hypertension	1.4e-06	3.25e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—INS—hypertension	1.4e-06	3.25e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—hypertension	1.38e-06	3.19e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—hypertension	1.36e-06	3.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM5—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX12—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GBA—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EPHX2—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DBH—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT2—hypertension	1.35e-06	3.14e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—hypertension	1.35e-06	3.12e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2J2—hypertension	1.31e-06	3.04e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—hypertension	1.29e-06	2.98e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DECR1—hypertension	1.27e-06	2.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLS2—hypertension	1.27e-06	2.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARG1—hypertension	1.27e-06	2.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COX5B—hypertension	1.27e-06	2.95e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGF2—hypertension	1.25e-06	2.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RHOA—hypertension	1.24e-06	2.88e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3R1—hypertension	1.23e-06	2.85e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—hypertension	1.23e-06	2.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALAD—hypertension	1.21e-06	2.8e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RELA—hypertension	1.16e-06	2.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCE1—hypertension	1.15e-06	2.67e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH7A1—hypertension	1.15e-06	2.67e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STS—hypertension	1.15e-06	2.67e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MTOR—hypertension	1.13e-06	2.63e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARG2—hypertension	1.1e-06	2.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CBS—hypertension	1.1e-06	2.56e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP4A11—hypertension	1.1e-06	2.56e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—hypertension	1.09e-06	2.52e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—XDH—hypertension	1.08e-06	2.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGIS—hypertension	1.06e-06	2.46e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP3A5—hypertension	1.06e-06	2.46e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC5A2—hypertension	1.06e-06	2.46e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—hypertension	1.05e-06	2.44e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—hypertension	1.04e-06	2.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TPH1—hypertension	1.03e-06	2.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCC1—hypertension	1.03e-06	2.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD11B1—hypertension	1.03e-06	2.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UCP3—hypertension	1.03e-06	2.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UCP2—hypertension	1.03e-06	2.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A3—hypertension	9.94e-07	2.3e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALAS1—hypertension	9.94e-07	2.3e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP11B2—hypertension	9.94e-07	2.3e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—hypertension	9.86e-07	2.28e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CDKN1A—hypertension	9.82e-07	2.28e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—hypertension	9.8e-07	2.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD3B1—hypertension	9.79e-07	2.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADA—hypertension	9.79e-07	2.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AQP1—hypertension	9.65e-07	2.24e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—FADS1—hypertension	9.65e-07	2.24e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK8—hypertension	9.59e-07	2.22e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—hypertension	9.56e-07	2.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CA9—hypertension	9.39e-07	2.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TBXAS1—hypertension	9.39e-07	2.17e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EP300—hypertension	9.35e-07	2.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5AP—hypertension	9.15e-07	2.12e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX15—hypertension	9.15e-07	2.12e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SRC—hypertension	9.09e-07	2.11e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HADHA—hypertension	8.93e-07	2.07e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LHB—hypertension	8.93e-07	2.07e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—hypertension	8.85e-07	2.05e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—KCNJ11—hypertension	8.73e-07	2.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSD3B2—hypertension	8.73e-07	2.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPA—hypertension	8.73e-07	2.02e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2C18—hypertension	8.37e-07	1.94e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LRP2—hypertension	8.37e-07	1.94e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MYC—hypertension	8.15e-07	1.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—hypertension	8.13e-07	1.88e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HSPG2—hypertension	8.06e-07	1.87e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—hypertension	7.97e-07	1.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5—hypertension	7.78e-07	1.8e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GLP1R—hypertension	7.78e-07	1.8e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH2—hypertension	7.12e-07	1.65e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HBA1—hypertension	6.93e-07	1.61e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP11A1—hypertension	6.89e-07	1.6e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC9A1—hypertension	6.77e-07	1.57e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—hypertension	6.77e-07	1.57e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CETP—hypertension	6.69e-07	1.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCLC—hypertension	6.69e-07	1.55e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—hypertension	6.69e-07	1.55e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP17A1—hypertension	6.41e-07	1.48e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ENO1—hypertension	6.34e-07	1.47e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS1—hypertension	6.34e-07	1.47e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—hypertension	6.12e-07	1.42e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CTGF—hypertension	6.1e-07	1.41e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GOT2—hypertension	6.05e-07	1.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMGCR—hypertension	6.05e-07	1.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADRA2A—hypertension	5.92e-07	1.37e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—hypertension	5.65e-07	1.31e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TH—hypertension	5.54e-07	1.28e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CALM2—hypertension	5.52e-07	1.28e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC2A4—hypertension	5.39e-07	1.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCG—hypertension	5.39e-07	1.25e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GOT1—hypertension	5.22e-07	1.21e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STK11—hypertension	5.07e-07	1.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP19A1—hypertension	5.07e-07	1.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COMT—hypertension	4.71e-07	1.09e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARGC1A—hypertension	4.65e-07	1.08e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNB3—hypertension	4.65e-07	1.08e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—hypertension	4.63e-07	1.07e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—hypertension	4.57e-07	1.06e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GNAS—hypertension	4.53e-07	1.05e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOB—hypertension	4.43e-07	1.03e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—hypertension	4.31e-07	9.99e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LPL—hypertension	4.23e-07	9.8e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY5—hypertension	4.14e-07	9.6e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPX1—hypertension	4.13e-07	9.56e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRKCA—hypertension	4.09e-07	9.47e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A1—hypertension	4.09e-07	9.47e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CD36—hypertension	4.02e-07	9.31e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—hypertension	3.81e-07	8.83e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARA—hypertension	3.74e-07	8.66e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AGT—hypertension	3.62e-07	8.39e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CALM1—hypertension	3.56e-07	8.25e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—hypertension	3.55e-07	8.22e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAV1—hypertension	3.51e-07	8.14e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOA1—hypertension	3.51e-07	8.12e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPARG—hypertension	3.09e-07	7.16e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—hypertension	3.05e-07	7.06e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INS—hypertension	3.03e-07	7.02e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—hypertension	2.78e-07	6.44e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—hypertension	2.66e-07	6.16e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3R1—hypertension	2.66e-07	6.16e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—hypertension	2.43e-07	5.63e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—hypertension	2.12e-07	4.91e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EP300—hypertension	2.02e-07	4.68e-06	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—hypertension	1.22e-07	2.83e-06	CbGpPWpGaD
